Imaging-based endpoints
The subjects underwent multiple assessments to evaluate the inflammatory skin response before the IMQ challenge and 24, 48, 72, 168, and 216 h after IMQ application. A single treatment site was selected to evaluate non-invasive endpoints throughout the study period (